Rspondin-Lgr Axis in Bone Regeneration

骨再生中的 Rspondin-Lgr 轴

基本信息

项目摘要

There is an urgent clinical need to develop new therapeutics to promote bone regeneration. A critical aspect of the bone healing process begins with the expansion of periosteal progenitors that occurs immediately after injury and then the differentiation of these progenitors to bone forming osteoblasts and chondrocytes, yet mechanisms that control skeletal progenitor/stem cell activation, expansion, and differentiation in response to injury are poorly described. Our project will study the role of the R-spondin (ligand) – Lgr (receptor) signaling axis in regulating these progenitors and bone regeneration. R-spondins (roof plate specific spondin) are a family of four secreted matricellular proteins (Rspo1-4) that bind to Leucine-rich repeat-containing G-protein coupled receptors 4/5/6 (Lgrs). Rspo-Lgr interaction potentiate canonical Wnt pathway by preventing the turnover of Wnt Frizzled receptors, and hence determines canonical Wnt signaling levels. While canonical Wnt signaling is known to play an important role in bone regeneration, very little research has explored positive modulators of Wnt signaling. In particular, the requirement of Rspo-Lgr in the context of fracture healing has never been examined due to lack of appropriate models. Our primary goal is to define the requirement of Rspo2/3 and Lgr6 in mesenchymal progenitors in response to bone injury. We have defined three specific aims to address this goal. In Aim1, we will use single and compound Rspo2 and Rspo3 floxed mice crossed with an alphaSMACreERT2 mouse to disrupt the Rspo2/3 genes in mesenchymal progenitors at the time of fracture. Bone healing will be assessed using microCT, histology, molecular analysis, and mechanical testing. Alterations in canonical Wnt signaling and osteogenic potential of Rspo2/3 deficient progenitors will be assessed. In Aim 2, Lgr6 knockout mice will be investigated for their bone healing properties using parameters similar to Aim 1. In Aim 3, Rspo2 will be delivered to bone injury sites and the impact on BMP and Wnt signaling, progenitor activation and differentiation, and bone healing assessed. Completion of this project will identify the requirement of Rspo2/3-Lgr6 interaction in fracture healing and will provide new therapeutic directions for enhancing bone healing.
临床上迫切需要开发新的治疗方法来促进骨再生。一 骨愈合过程的关键方面始于骨膜祖细胞的扩张 然后这些祖细胞分化成骨 形成成骨细胞和软骨细胞,但控制骨骼祖细胞/干细胞的机制 对损伤后的激活、扩张和分化的描述很少。我们的项目 将研究R-spondin(配体)- Lgr(受体)信号传导轴在调节这些过程中的作用。 祖细胞和骨再生。R-spondins(顶板特异性spondin)是一个四个家族 分泌的基质细胞蛋白(Rspo 1 -4),与富含亮氨酸的重复序列的G蛋白结合 偶联受体4/5/6(LGR)。Rspo-Lgr相互作用通过增强经典Wnt途径 阻止Wnt卷曲受体的周转,因此决定了典型的Wnt 信号水平。虽然已知典型的Wnt信号传导在骨骼中起重要作用, 再生,很少有研究探索Wnt信号传导的正调节剂。在 特别地,在骨折愈合的背景下对Rspo-Lgr的需求从未被 由于缺乏合适的模型。我们的主要目标是定义 间充质祖细胞中的Rspo 2/3和Lgr 6对骨损伤的反应我们已经定义 三个具体目标来实现这一目标。在目标1中,我们将使用单个和复合Rspo 2, Rspo 3 floxed小鼠与alphaSMACreERT 2小鼠杂交,以破坏细胞中的Rspo 2/3基因。 间充质祖细胞在骨折的时候。将使用microCT评估骨愈合, 组织学、分子分析和机械测试。经典Wnt信号传导的改变 并评估Rspo 2/3缺陷祖细胞的成骨潜力。在目标2中,Lgr 6 将使用类似于以下的参数研究敲除小鼠的骨愈合特性: 目标1。在目标3中,Rspo 2将被递送到骨损伤部位,并对BMP和Wnt的影响进行了研究。 信号传导、祖细胞活化和分化以及骨愈合。完成 本项目将确定骨折愈合中Rspo 2/3-Lgr 6相互作用的要求,并将 为促进骨愈合提供了新的治疗方向。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kurt David Hankenson其他文献

Kurt David Hankenson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kurt David Hankenson', 18)}}的其他基金

FASEB SRC: Matricellular Proteins: Fundamental Concepts and New Directions
FASEB SRC:基质细胞蛋白:基本概念和新方向
  • 批准号:
    10468385
  • 财政年份:
    2022
  • 资助金额:
    $ 37.94万
  • 项目类别:
Rspondin-Lgr Axis in Bone Regeneration
骨再生中的 Rspondin-Lgr 轴
  • 批准号:
    10260493
  • 财政年份:
    2020
  • 资助金额:
    $ 37.94万
  • 项目类别:
Rspondin-Lgr Axis in Bone Regeneration
骨再生中的 Rspondin-Lgr 轴
  • 批准号:
    10261766
  • 财政年份:
    2020
  • 资助金额:
    $ 37.94万
  • 项目类别:
ORS-ISFR 17th Biennial Conference: Thinking big on fracture repair
ORS-ISFR 第 17 届双年会:对骨折修复的大思考
  • 批准号:
    10066004
  • 财政年份:
    2020
  • 资助金额:
    $ 37.94万
  • 项目类别:
Rspondin-Lgr Axis in Bone Regeneration
骨再生中的 Rspondin-Lgr 轴
  • 批准号:
    10669815
  • 财政年份:
    2020
  • 资助金额:
    $ 37.94万
  • 项目类别:
Regulators of Ischemic Fracture Healing
缺血性骨折愈合的调节因子
  • 批准号:
    9921196
  • 财政年份:
    2015
  • 资助金额:
    $ 37.94万
  • 项目类别:
Notch signaling and Bone Fracture Healing
Notch信号传导和骨折愈合
  • 批准号:
    10589870
  • 财政年份:
    2011
  • 资助金额:
    $ 37.94万
  • 项目类别:
Notch signaling and Bone Fracture Healing
Notch信号传导和骨折愈合
  • 批准号:
    10363359
  • 财政年份:
    2011
  • 资助金额:
    $ 37.94万
  • 项目类别:
In vivo microcomputed tomography
体内微型计算机断层扫描
  • 批准号:
    7389369
  • 财政年份:
    2008
  • 资助金额:
    $ 37.94万
  • 项目类别:
BMP6 Induction of Human Mesenchymal Stem Cell Osteoblast Differentiation
BMP6 诱导人间充质干细胞成骨细胞分化
  • 批准号:
    7436259
  • 财政年份:
    2006
  • 资助金额:
    $ 37.94万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Research Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Standard Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
  • 批准号:
    10065645
  • 财政年份:
    2023
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 37.94万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了